The Work We Fund

Funded projects
1,320+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programmes
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programmes.

Young Prostate Cancer Investigator Scholarships

Movember Funding to Date

NZD 115,000

What we seek to achieve

Engage some of the most innovative young researchers in New Zealand to concentrate on key prostate cancer issues.

Country
New Zealand
Implemented by
Cancer Society NZ (CSNZ)
Project start date
January 2013
Project Status
Project Completed

About the project

  • Advertised for applicants for the scholarships through various relevant  medical institutions such as the Schools of Medicine.
  • Criteria was set by the Cancer Society’s Medical Director, Chris Atkinson, who also oversaw selection process. The criteria included a description from applicants about how their intended research would benefit patients with prostate cancer.
  • Documentation of institutional support, including mentoring and peer review, was required.
  • The two successful applicants were required to demonstrate that their research is likely to be high impact, leading to the reduction of the burden of prostate cancer in New Zealand.

>
Page 1 of 29